Skip to main content

Teva to reduce size of board after June shareholder's' meeting

JERUSALEM, April 26 (Reuters) - Three directors are stepping down from the board at Teva Pharmaceutical Industries and only one new director is being nominated to replace them, the generic drugmaker said on Thursday.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.